| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $232M | $228M | $207M | 1.6% | 11.7% |
| Op. Income | $33M | $31M | $23M | 8.2% | 47.5% |
| Gross Margin | 25.0% | 23.2% | 20.9% | 1.9pp | 4.1pp |
| Net Margin | 11.4% | 10.4% | 9.4% | 1.0pp | 2.0pp |
| EPS (Diluted) | $0.51 | $0.46 | $0.37 | 10.9% | 37.8% |
| Free Cash Flow | $14M | $32M | $5M | -55.6% | 174.3% |
| Item | Amount |
|---|---|
| REVENUE | $232M |
| Cost of Revenue | $174M |
| GROSS PROFIT | $58M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $25M |
| SG&A Expenses | $25M |
| Other Expenses | $0 |
| Operating Expenses | $25M |
| Cost & Expenses | $198M |
| OPERATING INCOME | $33M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $26M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $8M |
| EBIT | $33M |
| EBITDA | $41M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $232M |
| Cost of Revenue | $174M |
| GROSS PROFIT | $58M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $25M |
| SG&A Expenses | $25M |
| Other Expenses | $0 |
| Operating Expenses | $25M |
| Cost & Expenses | $198M |
| OPERATING INCOME | $33M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $26M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $26M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $26M |
| D&A | $8M |
| EBIT | $33M |
| EBITDA | $41M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $26M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | -$4M |
| Other Non-Cash Items | $2M |
| Change in Working Capital | -$11M |
| OPERATING CASH FLOW | $23M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$9M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$9M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $2M |
| NET CASH FROM FINANCING | -$7M |
| FREE CASH FLOW | $14M |
| Net Change in Cash | $8M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $171M |
| Short-Term Investments | $0 |
| Net Receivables | $104M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $387M |
| PP&E (Net) | $113M |
| Goodwill | $37M |
| Intangible Assets | $438.0K |
| Long-Term Investments | $0 |
| Tax Assets | $9M |
| Other Non-Current Assets | $454.0K |
| TOTAL NON-CURRENT ASSETS | $159M |
| TOTAL ASSETS | $546M |
| Account Payables | $15M |
| Short-Term Debt | $0 |
| Deferred Revenue | $132M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $204M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $20M |
| TOTAL LIABILITIES | $224M |
| Common Stock | $5.0K |
| Additional Paid-In Capital | $250M |
| Retained Earnings | $903M |
| Treasury Stock | -$832M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $322M |
| Minority Interest | $0 |
| TOTAL EQUITY | $322M |
| TOTAL LIABILITIES & EQUITY | $546M |
| Total Debt | $28M |
| Net Debt | -$143M |
